Peer Review reports
From: Denosumab for treating periprosthetic osteolysis: a feasibility study
| Original Submission | ||
|---|---|---|
| 11 Aug 2024 | Submitted | Original manuscript |
| 13 Aug 2024 | Author responded | Author comments - Michael Axenhus |
| 14 Aug 2024 | Author responded | Author comments - Michael Axenhus |
| Resubmission - Version 2 | ||
| 13 Aug 2024 | Submitted | Manuscript version 2 |
| 16 Oct 2024 | Reviewed | Reviewer Report |
| 31 Oct 2024 | Reviewed | Reviewer Report - Poul Torben Nielsen |
| 26 Mar 2025 | Author responded | Author comments - Michael Axenhus |
| Resubmission - Version 3 | ||
| 26 Mar 2025 | Submitted | Manuscript version 3 |
| 27 Mar 2025 | Author responded | Author comments - Michael Axenhus |
| Resubmission - Version 4 | ||
| 27 Mar 2025 | Submitted | Manuscript version 4 |
| Publishing | ||
| 31 Mar 2025 | Editorially accepted | |
| 8 Apr 2025 | Article published | 10.1186/s13104-025-07216-0 |
You can find further information about peer review here.